EVOME MEDICAL TECHNOLOGIES INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Evome Medical Technologies Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q4 2023.
  • Evome Medical Technologies Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 73.5M shares, a 33.2% increase year-over-year.
  • Evome Medical Technologies Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 73.5M shares.
  • Evome Medical Technologies Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 43.6M shares, a 29.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 73.5M +18.3M +33.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 94.7M +40M +73.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 73.9M +21.1M +39.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 62.4M +12.4M +24.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 55.1M +10.4M +23.1% Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-17
Q3 2022 54.7M +10M +22.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 52.9M +17.9M +51.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 50M +16.2M +48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 44.8M +11M +32.5% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-17
Q3 2021 44.7M -1.15M -2.51% Jun 1, 2021 Aug 31, 2021 10-Q 2022-10-17
Q2 2021 35M +1.21M +3.58% Mar 1, 2021 May 31, 2021 10-Q 2022-07-15
Q1 2021 33.8M Dec 1, 2020 Feb 28, 2021 10-K 2022-05-31
Q4 2020 33.8M Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-14
Q3 2020 45.8M Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-15
Q2 2020 33.8M Mar 1, 2020 May 31, 2020 10-Q/A 2021-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.